ZACHARY RIPLEY: Open Payments
NPI 1629450218 · LEWISTON, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,342 in 83 payments from 18 companies in 2025. Trend: 2023 $13 · 2024 $372 · 2025 $1,342
Food & beverage: $1,342
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $210 |
| ABBVIE INC. | 16 | $200 |
| AstraZeneca Pharmaceuticals LP | 6 | $185 |
| GlaxoSmithKline, LLC. | 17 | $168 |
| Teva Pharmaceuticals USA, Inc. | 3 | $98 |
| Lundbeck LLC | 4 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Novo Nordisk Inc | 3 | $48 |
| Exact Sciences Corporation | 2 | $46 |
Products named: NURTEC ODT, AIRSUPRA, TRELEGY ELLIPTA, QULIPTA, REXULTI, AUSTEDO XR, CAPLYTA, UBRELVY.
Industry payments across ID — which companies pay providers there.
